Shopping Cart 0
Cart Subtotal
AED 0

TheraDiag SA (ALTER) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 918

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 1835

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 2753

Details

Summary

Theradiag SA (Theradiag), formerly Biomedical Diagnostics SA, is a biotechnology company that develops, manufactures, and markets vitro diagnostic products. The company offers product for the diagnostics of auto-immune diseases, allergies and infectious diseases. It develops product panels for diagnosing autoimmune diseases, allergies, and infectious diseases. Theradiag provides tests using techniques and automatic devices and solutions for high-speed diagnostics. The company also offers multi-parametric monitoring system for treatment of autoimmune diseases by anti-TNF. It provides in-vitro diagnostic products in the fields of auto-immunity, allergies, infectious diseases and, more recently, oncology and molecular biology. The company serves autoimmune disease diagnostic markets. Theradiag is headquartered in Paris, France.

TheraDiag SA (ALTER)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

TheraDiag SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

TheraDiag SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

TheraDiag SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

TheraDiag SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

TheraDiag SA, Medical Devices Deals, 2012 to YTD 2018 9

TheraDiag SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

TheraDiag SA, Pharmaceuticals & Healthcare, Deal Details 11

Partnerships 11

TheraDiag Enters Into Co-Development Agreement With Regional Cancer Institute of Montpellier 11

Equity Offering 12

TheraDiag Raises USD4.5 Million in Private Placement of Shares 12

TheraDiag Raises USD2.78 Million in Private Placement of Shares 13

TheraDiag Raises Funds in IPO of Shares 14

Acquisition 15

Theradiag Acquires Prestizia, Developer Of microRNA Technology 15

TheraDiag SA-Key Competitors 16

TheraDiag SA-Key Employees 17

TheraDiag SA-Locations And Subsidiaries 18

Head Office 18

Other Locations & Subsidiaries 18

Recent Developments 19

Strategy And Business Planning 19

Dec 19, 2017: THERADIAG provides an update on Prestizia and its partnership with HOB Biotech 19

Financial Announcements 20

Sep 19, 2018: Theradiag: 2018 interim results and business update 20

Apr 10, 2018: Theradiag reports its 2017 annual results and sales for first quarter 2018 22

Feb 20, 2018: Theradiag Announces 2017 Annual Sales and Cash Flow at End 2017 24

Oct 26, 2017: Theradiag: Revenues at the end of September 30, 2017 25

Sep 19, 2017: Theradiag: Results and activity for the first half of 2017 Continued improvement in results 26

Jul 25, 2017: Theradiag: Further Strong Sales Growth in the First Half of 2017: +9% 28

Apr 27, 2017: THERADIAG Announces First-quarter 2017 Revenues 29

Apr 27, 2017: Theradiag: First-Quarter 2017 Revenues 30

Mar 01, 2017: THERADIAG: Full-year 2016 results 31

Corporate Communications 33

Oct 09, 2018: Evolution of Theradiag's governance 33

Mar 01, 2017: Appointment of Dominique Costantini and Dominique Takizawa to Theradiag's Board of Directors 34

Appendix 35

Methodology 35

About GlobalData 35

Contact Us 35

Disclaimer 35


List Of Figure

List of Figures

TheraDiag SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

TheraDiag SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

TheraDiag SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

TheraDiag SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

TheraDiag SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

TheraDiag SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

TheraDiag SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

TheraDiag SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

TheraDiag SA, Medical Devices Deals, 2012 to YTD 2018 9


List Of Table

List of Tables

TheraDiag SA, Pharmaceuticals & Healthcare, Key Facts, 2017 2

TheraDiag SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

TheraDiag SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

TheraDiag SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

TheraDiag SA, Deals By Therapy Area, 2012 to YTD 2018 8

TheraDiag SA, Medical Devices Deals, 2012 to YTD 2018 9

TheraDiag SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

TheraDiag Enters Into Co-Development Agreement With Regional Cancer Institute of Montpellier 11

TheraDiag Raises USD4.5 Million in Private Placement of Shares 12

TheraDiag Raises USD2.78 Million in Private Placement of Shares 13

TheraDiag Raises Funds in IPO of Shares 14

Theradiag Acquires Prestizia, Developer Of microRNA Technology 15

TheraDiag SA, Key Competitors 16

TheraDiag SA, Key Employees 17

TheraDiag SA, Subsidiaries 18

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

TheraDiag SA, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Company Profile

Company Profile Title

Summary

Theradiag SA (Theradiag), formerly Biomedical Diagnostics SA, is a biotechnology company that develops, manufactures, and markets vitro diagnostic products. The company offers product for the diagnostics of auto-immune diseases, allergies and infectious diseases. It develops product panels for diagnosing autoimmune diseases, allergies, and infectious diseases. Theradiag provides tests using techniques and automatic devices and solutions for high-speed diagnostics. The company also offers multi-parametric monitoring system for treatment of autoimmune diseases by anti-TNF. It provides in-vitro diagnostic products in the fields of auto-immunity, allergies, infectious diseases and, more recently, oncology and molecular biology. The company serves autoimmune disease diagnostic markets. Theradiag is headquartered in Paris, France.

TheraDiag SA (ALTER)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

TheraDiag SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

TheraDiag SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

TheraDiag SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

TheraDiag SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

TheraDiag SA, Medical Devices Deals, 2012 to YTD 2018 9

TheraDiag SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

TheraDiag SA, Pharmaceuticals & Healthcare, Deal Details 11

Partnerships 11

TheraDiag Enters Into Co-Development Agreement With Regional Cancer Institute of Montpellier 11

Equity Offering 12

TheraDiag Raises USD4.5 Million in Private Placement of Shares 12

TheraDiag Raises USD2.78 Million in Private Placement of Shares 13

TheraDiag Raises Funds in IPO of Shares 14

Acquisition 15

Theradiag Acquires Prestizia, Developer Of microRNA Technology 15

TheraDiag SA-Key Competitors 16

TheraDiag SA-Key Employees 17

TheraDiag SA-Locations And Subsidiaries 18

Head Office 18

Other Locations & Subsidiaries 18

Recent Developments 19

Strategy And Business Planning 19

Dec 19, 2017: THERADIAG provides an update on Prestizia and its partnership with HOB Biotech 19

Financial Announcements 20

Sep 19, 2018: Theradiag: 2018 interim results and business update 20

Apr 10, 2018: Theradiag reports its 2017 annual results and sales for first quarter 2018 22

Feb 20, 2018: Theradiag Announces 2017 Annual Sales and Cash Flow at End 2017 24

Oct 26, 2017: Theradiag: Revenues at the end of September 30, 2017 25

Sep 19, 2017: Theradiag: Results and activity for the first half of 2017 Continued improvement in results 26

Jul 25, 2017: Theradiag: Further Strong Sales Growth in the First Half of 2017: +9% 28

Apr 27, 2017: THERADIAG Announces First-quarter 2017 Revenues 29

Apr 27, 2017: Theradiag: First-Quarter 2017 Revenues 30

Mar 01, 2017: THERADIAG: Full-year 2016 results 31

Corporate Communications 33

Oct 09, 2018: Evolution of Theradiag's governance 33

Mar 01, 2017: Appointment of Dominique Costantini and Dominique Takizawa to Theradiag's Board of Directors 34

Appendix 35

Methodology 35

About GlobalData 35

Contact Us 35

Disclaimer 35


List Of Figure

List of Figures

TheraDiag SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

TheraDiag SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

TheraDiag SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

TheraDiag SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

TheraDiag SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

TheraDiag SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

TheraDiag SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

TheraDiag SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

TheraDiag SA, Medical Devices Deals, 2012 to YTD 2018 9


List Of Table

List of Tables

TheraDiag SA, Pharmaceuticals & Healthcare, Key Facts, 2017 2

TheraDiag SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

TheraDiag SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

TheraDiag SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

TheraDiag SA, Deals By Therapy Area, 2012 to YTD 2018 8

TheraDiag SA, Medical Devices Deals, 2012 to YTD 2018 9

TheraDiag SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

TheraDiag Enters Into Co-Development Agreement With Regional Cancer Institute of Montpellier 11

TheraDiag Raises USD4.5 Million in Private Placement of Shares 12

TheraDiag Raises USD2.78 Million in Private Placement of Shares 13

TheraDiag Raises Funds in IPO of Shares 14

Theradiag Acquires Prestizia, Developer Of microRNA Technology 15

TheraDiag SA, Key Competitors 16

TheraDiag SA, Key Employees 17

TheraDiag SA, Subsidiaries 18

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

TheraDiag SA, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.